One domestic Corona 19 treatment has been approved by the Ministry of Food and Drug Safety.
Today (15th), Kwon Joon-wook, head of the 2nd Division of the Central Defense Response Headquarters, said at a briefing that “The Clinical Trial Review Committee (IRB) is deliberating.”
“(Therapeutic agent) is for the purpose of treating patients in the medical field, apart from clinical trials.”
The heavy script believes that a cure will be administered soon.
–– They said they were preparing for the Phase 3 exam.
“Phase 2 clinical trials for blood treatment drugs are in progress,” said Kwon, head of the 2nd vice president. “All 41 patients were enrolled, and 4,096 people donated plasma.”
He explained, “After analyzing the results, we will apply for conditional approval and proceed with the phase 3 test.”
Regarding the vaccine, he said, “Our country is aiming to complete phase 3 clinical trials of domestic vaccines by the second half of next year.”
Currently, there are 3 vaccines under development in Korea: 2 DNA vaccines and 1 synthetic antigen vaccine.
“Vaccines are repeated many failures and successes over and over again,” said Kwon’s second vice president. “If this is taken into account, successes and failures can be repeated many times.”
–
—
–
–
